Literature DB >> 4076842

Simulation of primary haemostasis in vitro.

M A Kratzer, G V Born.   

Abstract

Primary haemostasis was simulated in vitro under standardized geometrical, rheological and biochemical conditions. The system was based on the hypothesis that adenine nucleotides, especially adenosine 5'-diphosphate, released from injured vessel wall cells play an important role for the initial platelet aggregation following lesion of small vessels. The device allows the reproducible measurement of in vitro bleeding time and volume in small samples of whole blood.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4076842     DOI: 10.1159/000215173

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  13 in total

1.  In vitro bleeding test with PFA-100-aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease.

Authors:  A J Peters; M Borries; F Gradaus; T W Jax; F C Schoebel; B E Strauer
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300

Review 2.  Assessment of oral antithrombotic therapy by platelet function testing.

Authors:  Udaya S Tantry; Paul A Gurbel
Journal:  Nat Rev Cardiol       Date:  2011-07-19       Impact factor: 32.419

3.  [The effects of aprotinin. Blood loss and coagulation parameters in orthotopic liver transplantation: A clinical-experimental, prospective and randomized double-blind study].

Authors:  M A Kratzer; S C Azad; J Groh; M Welte; M Haller; E Pratschke
Journal:  Anaesthesist       Date:  1997-04       Impact factor: 1.041

4.  In vitro bleeding test--a sensitive method for the detection of platelet function impairment and a potential test for the control of low-dose aspirin efficacy.

Authors:  V Kretschmer; B Schikor; D Soehngen; G Dietrich
Journal:  Blut       Date:  1989-08

5.  In vitro analysis of platelet function in acute aneurysmal subarachnoid haemorrhage.

Authors:  Christian von der Brelie; Alexander Subai; Verena Limperger; Veit Rohde; Astrid Dempfle; Azize Boström
Journal:  Neurosurg Rev       Date:  2017-07-24       Impact factor: 3.042

6.  Clinical application of a new in vitro bleeding time device on surgical patients.

Authors:  T Tsujinaka; T Itoh; Y Uemura; M Sakon; J Kambayashi; T Mori
Journal:  Jpn J Surg       Date:  1988-07

7.  Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.

Authors:  E V Negrescu; B Grünberg; M A Kratzer; R Lorenz; W Siess
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

8.  In vitro analysis of polyurethane foam as a topical hemostatic agent.

Authors:  Ferdinand I Broekema; Wim van Oeveren; Johan Zuidema; Susan H Visscher; Rudolf R M Bos
Journal:  J Mater Sci Mater Med       Date:  2011-03-19       Impact factor: 3.896

Review 9.  [Rational hemostatic screening].

Authors:  N Maurin
Journal:  Med Klin (Munich)       Date:  1999-03-15

10.  The Platelet Function Analyzer (PFA-100) as a Screening Tool in Neurosurgery.

Authors:  Ralf Karger; Karoline Reuter; Jochen Rohlfs; Christopher Nimsky; Ulrich Sure; Volker Kretschmer
Journal:  ISRN Hematol       Date:  2012-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.